HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shingo Kariya Selected Research

Nervous System Diseases (Neurological Disorders)

1/2006Cytoprotective effect of novel histone deacetylase inhibitors against polyglutamine toxicity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shingo Kariya Research Topics

Disease

6Alzheimer Disease (Alzheimer's Disease)
04/2005 - 05/2002
3Neurodegenerative Diseases (Neurodegenerative Disease)
12/2014 - 05/2002
3Spinal Muscular Atrophy (Progressive Muscular Atrophy)
02/2014 - 08/2008
2Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
12/2014 - 08/2012
2Progressive Myoclonic Epilepsies (Progressive Myoclonic Epilepsy)
01/2006 - 01/2005
2MELAS Syndrome (Syndrome, MELAS)
04/2005 - 04/2005
1Demyelinating Diseases (Demyelinating Disease)
02/2024
1Body Weight (Weight, Body)
02/2024
1Chorea (Rheumatic Chorea)
02/2024
1Dyskinesias (Dyskinesia)
02/2024
1Tardive Dyskinesia
02/2024
1Malnutrition (Nutritional Deficiencies)
09/2022
1Locked-In Syndrome (Locked In Syndrome)
09/2022
1Alcoholism (Alcohol Abuse)
09/2022
1Brain Diseases (Brain Disorder)
09/2022
1Hyponatremia
09/2022
1Central Pontine Myelinolysis
09/2022
1Cardiomyopathies (Cardiomyopathy)
01/2019
1Muscular Diseases (Myopathy)
02/2015
1Muscle Weakness
02/2015
1Sarcoma (Soft Tissue Sarcoma)
12/2014
1Necrosis
03/2014
1Motor Neuron Disease (Primary Lateral Sclerosis)
02/2014
1Ataxia (Dyssynergia)
02/2007
1Nervous System Diseases (Neurological Disorders)
01/2006
1Parkinson Disease (Parkinson's Disease)
05/2005
1Mitochondrial Diseases (Mitochondrial Disease)
04/2005
1Stroke (Strokes)
04/2005
1Mitochondrial Encephalomyopathies (Mitochondrial Encephalomyopathy)
04/2005
1Lactic Acidosis
04/2005
1Brain Ischemia (Cerebral Ischemia)
12/2003

Drug/Important Bio-Agent (IBA)

6Proteins (Proteins, Gene)FDA Link
02/2015 - 08/2008
5humaninIBA
04/2005 - 05/2002
5Peptides (Polypeptides)IBA
04/2005 - 05/2002
2polyglutamineIBA
01/2006 - 01/2005
2Reactive Oxygen Species (Oxygen Radicals)IBA
05/2005 - 04/2005
2Adenosine Triphosphate (ATP)IBA
04/2005 - 04/2005
1Antipsychotic Agents (Antipsychotics)IBA
02/2024
1valbenazineIBA
02/2024
1SodiumIBA
09/2022
1IntegrinsIBA
01/2019
1Biomarkers (Surrogate Marker)IBA
12/2014
1Phosphotransferases (Kinase)IBA
03/2014
1Superoxide Dismutase-1IBA
08/2012
1DNA (Deoxyribonucleic Acid)IBA
02/2007
1Dopamine (Intropin)FDA LinkGeneric
05/2005
1Mitochondrial DNA (mtDNA)IBA
04/2005
1Genetic Markers (Genetic Marker)IBA
10/2003
1Amyloid beta-PeptidesIBA
05/2002

Therapy/Procedure

1Drug Therapy (Chemotherapy)
02/2024
1Therapeutics
09/2022
1Physical Therapy Modalities (Physical Therapy Technique)
09/2022